BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33888337)

  • 1. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
    Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation Sequencing Reveals Recurrent Somatic Mutations in Small Cell Neuroendocrine Carcinoma of the Uterine Cervix.
    Xing D; Zheng G; Schoolmeester JK; Li Z; Pallavajjala A; Haley L; Conner MG; Vang R; Hung CF; Wu TC; Ronnett BM
    Am J Surg Pathol; 2018 Jun; 42(6):750-760. PubMed ID: 29505425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix.
    Zhang SW; Luo RZ; Sun XY; Yang X; Yang HX; Xiong SP; Liu LL
    BMC Cancer; 2021 Mar; 21(1):332. PubMed ID: 33789601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
    Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
    PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing of mutational hotspots in cancer-related genes in small cell neuroendocrine cervical cancer.
    Frumovitz M; Burzawa JK; Byers LA; Lyons YA; Ramalingam P; Coleman RL; Brown J
    Gynecol Oncol; 2016 Jun; 141(3):588-591. PubMed ID: 27079212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational profiles of marker genes of cervical carcinoma in Bangladeshi patients.
    Sharmin S; Zohura FT; Islam MS; Shimonty A; Khan MA; Parveen R; Sharmin F; Ahsan CR; Islam ABMMK; Yasmin M
    BMC Cancer; 2021 Mar; 21(1):289. PubMed ID: 33736612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
    Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
    Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
    Lee HK; Kwon MJ; Ra YJ; Lee HS; Kim HS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Min KW; Kang SY
    Diagn Pathol; 2020 Oct; 15(1):126. PubMed ID: 33054840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 11. Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study.
    Ishida GM; Kato N; Hayasaka T; Saito M; Kobayashi H; Katayama Y; Sasou S; Yaegashi N; Kurachi H; Motoyama T
    Int J Gynecol Pathol; 2004 Oct; 23(4):366-72. PubMed ID: 15381906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
    Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
    Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer.
    Martell K; McIntyre JB; Kornaga EN; Chan AMY; Phan T; Köbel M; Enwere EK; Dean ML; Ghatage P; Lees-Miller SP; Doll CM
    Gynecol Oncol; 2020 Sep; 158(3):776-784. PubMed ID: 32653099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix.
    Cimic A; Vranic S; Arguello D; Contreras E; Gatalica Z; Swensen J
    Appl Immunohistochem Mol Morphol; 2021 Apr; 29(4):299-304. PubMed ID: 33208671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
    Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
    Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
    Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics and outcome of patients with small cell neuroendocrine carcinoma of the uterine cervix: case series and literature review.
    Wang Y; Mei K; Xiang MF; Li JM; Xie RM
    Eur J Gynaecol Oncol; 2013; 34(4):307-10. PubMed ID: 24020135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
    Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
    Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
    Wright AA; Howitt BE; Myers AP; Dahlberg SE; Palescandolo E; Van Hummelen P; MacConaill LE; Shoni M; Wagle N; Jones RT; Quick CM; Laury A; Katz IT; Hahn WC; Matulonis UA; Hirsch MS
    Cancer; 2013 Nov; 119(21):3776-83. PubMed ID: 24037752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
    Mabuchi S; Komura N; Sasano T; Sakata M; Matsuzaki S; Hisa T; Kamiura S; Morishima T; Miyashiro I
    Curr Oncol; 2023 Oct; 30(11):9428-9436. PubMed ID: 37999102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.